East Hanover, NJNCT07779460Now EnrollingIRB Ready

Multiple Sclerosis Clinical Trial in East Hanover, NJ

Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in East Hanover. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this East Hanover location

Preparing your pre-screening questions…

Expert Care in East Hanover

Access multiple sclerosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple sclerosis treatment provided free

Apply for This East Hanover Location

Check if you qualify for this multiple sclerosis clinical trial in East Hanover, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to East Hanover

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit East Hanover site if eligible
  4. 4Begin participation

About This Multiple Sclerosis Study in East Hanover

This study aims to generate real-world evidence on the clinical effectiveness and economic burden of ofatumumab (OMB) versus ocrelizumab (OCR) in patients diagnosed with multiple sclerosis (MS) in the United States (US). Clinical effectiveness will be assessed using annualized relapse rate (ARR), while economic burden will be assessed using healthcare resource utilization (HCRU) and healthcare costs (HCC). This study will use two primary data sources that capture longitudinal, de-identified healthcare utilization derived from claims submitted for reimbursement.

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Patients in the pooled OMB and pooled OCR cohorts are required to meet the following eligibility criteria:
≥1 incident claim for OMB (pooled OMB cohort) or OCR (pooled OCR cohort) in the patient identification period.
No claims for OMB or OCR within the 12 months prior to the index date. The index date is the date of the first OMB or OCR claim.
≥2 outpatient (OP) medical claims (at least 30 days apart) with a diagnosis code for MS (International Classification of Diseases, Tenth Revision, Clinical Modification \[ICD-10-CM\] code: G35) in any position, with the first claim occurring in the 12 months prior to or on index date and the second claim up to 6 months after index date, or ≥1 inpatient (IP) claim with MS recorded as the primary diagnosis in the 12 months prior to or on index date.
≥18 years of age on index date.
Continuous healthcare plan enrollment for ≥12 months prior to index date and ≥6 months after index date.
Persistent use of OMB (pooled OMB cohort) or OCR (pooled OCR cohort) for ≥6 months after index date. Patients in the treatment-naïve OMB and treatment-naïve OCR cohorts are required to meet the following eligibility criteria:
Included in pooled OMB cohort or pooled OCR cohort.
No claims for a disease-modifying therapy (DMT) used for the treatment of MS in the 12-month baseline period.

Exclusion Criteria

• Patients who do not meet the study inclusion criteria. Other protocol-defined inclusion/exclusion criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in East Hanover?

Yes, this clinical trial (NCT07779460) has an active research site in East Hanover, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Sclerosis Treatment Options in East Hanover, NJ

If you're searching for multiple sclerosis treatment options in East Hanover, NJ, this clinical trial (NCT07779460) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our East Hanover research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple sclerosis clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in East Hanover, NJ

See all multiple sclerosis clinical trials recruiting in East Hanover — not just this study.

Browse Multiple Sclerosis Trials in East Hanover →

Browse More Trials by Condition

Multiple Sclerosis TrialsAll Conditions →

Ready to Join in East Hanover?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · East Hanover, NJ